Press Releases

  • All
  • Press Release 2022
  • Press Release 2023
  • Press Releases 2009
  • Press Releases 2010
  • Press Releases 2011
  • Press Releases 2012
  • Press Releases 2014
  • Press Releases 2017
  • Press Releases 2018
  • Press Releases 2019
  • Press Releases 2020
  • Press Releases 2021

  Paiania, September 28, 2018 – Lavipharm demonstrated a solid performance in the first half of 2018. Despite the significant increase of obligatory rebates and clawbacks that burdened the pharma industry, Lavipharm sustained its Turnover and profitability, both at a consolidated and at parent company levels. More...

  Peania, October 24th 2018 - Lavipharm S.A., pursuant to Article 19 of the European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that T & A Holdings (Luxembourg) sarl, a company related to Lavipharm SA's Executive Chairman, Mr. Athanasios...

  Peania, December 6th 2018 - Lavipharm S.A., pursuant to Article 19 of the European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that, on December 3rd, 2018, T & A Holdings (Luxembourg) sarl, a company related to Lavipharm SA's...

  Παιανία, 28 Απριλίου 2017 – Κατά το 2016, παρά τη μείωση της δημόσιας φαρμακευτικής δαπάνης, την περαιτέρω συμπίεση του κλάδου της Υγείας και τη συνεχιζόμενη αβεβαιότητα, η Lavipharm παρουσιάζει ενίσχυση του Κύκλου Εργασιών της, που προέρχεται κυρίως από τη σημαντική αύξηση των Πωλήσεων της εκτός...

  Peania, September 29th, 2017 – In the First Half of 2017, Lavipharm reports increased Consolidated Turnover mainly attributed to international sales, despite economic pressures, sustained regulatory constraints and decrease of the pharmaceutical market in Greece. At the same time, the sharp drop in loans and...